| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |